Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GK530G (Epiduo) vs Monotherapies in Acne Vulgaris
NCT02073448Phase 3Completed
- Sponsor
- Galderma
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of adapalene, benzoyl peroxide in acne vulgaris, sponsored by Galderma. Started Mar 2014; status: completed.
02
Drugs
adapalenebenzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02073448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02073448.